Bristol Myers (BMY)’ treatment of small cell lung cancer, atigotatug plus nivolumab fixed dose combination, received FDA ...

Patients with lung adenocarcinoma typically carry a mutation in the Epidermal Growth Factor Receptor (EGFR) gene, making them ...

34,691 people played the daily Crossword recently. Can you solve it faster than others?34,691 people played the daily ...

Scientists at the University of Virginia School of Medicine have uncovered a key reason why some people continue to ...

Lung cancer remains one of the leading causes of cancer-related mortality, with lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) representing the most prevalent subtypes of non-small ...

Life-threatening lung cancer has taught me many valuable lessons and made my new normal so fulfilling. My life has changed ...

With symptoms that often mimic other respiratory conditions, ILD is frequently misdiagnosed or unrecognized. However, in the Philippines, hope is in the horizon.

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.